
    
      The study aims to evaluate radiomic markers in breast tumors to evaluate metastatic risk
      based on radiomic features following primary therapy. The investigators aim to analyze images
      at various time intervals before, during and after primary treatments using two advanced
      imaging techniques (DCE-MRI & DWI-MRI).
    
  